Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Norsk Hydro Receives Chinese Regulatory Approval For JV With Orkla

Norsk Hydro ASA (NHY: Quote,NHYDY.PK,NHYDY.PK) said Monday that the Chinese competition authorities have approved the closing of the transaction whereby Hydro and Orkla will have 50/50 ownership of the planned aluminium solutions Sapa joint venture.

The approval from the Chinese competition authorities marks the conclusion of the competition law assessment of the agreement, necessary for closure.

The transaction has already been approved by the EU Commission, the U.S. Department of Justice and relevant competition authorities in several other countries.

The parties plans to close the transaction as soon as possible and with accounting effect from September.

Click here to receive FREE breaking news email alerts for Norsk Hydro ASA and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Stocks moved notably higher over the course of the trading day on Friday after initially showing a lack of direction. The gains on the day extended the recent upward trend by the markets, with the tech-heavy Nasdaq reaching its best closing level in almost a month. Looking to capitalize on news of an Ebola diagnosis in New York City, Republican Senate candidate Scott Brown issued a statement Friday criticizing his Democratic opponent Sen. Jeanne Shaheen, D-N.H., for "waffling" on a travel ban. In another troubling sign for Democrats, the results of a Gallup poll released on Friday show that Tea Party Republicans are much more motivated to vote in the upcoming midterm elections than other Americans. The poll found that 73 percent of Tea Party Republicans are "extremely" or "very" motivated to vote in this year's elections.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.